0001493152-24-013870 Sample Contracts

Omnibus Waiver and Amendment

Omnibus Waiver and Amendment • April 8th, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Omnibus Waiver and Amendment
• Filed
  April 8th, 2024
• Company
  MyMD Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Omnibus Waiver and Amendment (this “Agreement”), dated as of April __, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the signature pages attached hereto (the “Investors”).